The present invention relates to polymerizable monomers for applications in medicine and biotechnology and synthesis thereof. The polymerizable ligands containing NAcetyl Glucosamine bind more strongly to lysozyme than NAG itself. The binding is further enhanced when a spacer arm, for example 6-Amino Caproic Acid (6-ACA) is introduced in the structure. The conjugated ligands could be used for prevention and treatment of bacterial and viral infections Moreover these ligands can be coupled to stimuli sensitive polymers and used for the recovery of biomolecules The methodology can be extended to other ligands such as sialic acid and the corresponding polymers used for preventil1g influenza and lor rotavirus infections
本发明涉及用于医学和
生物技术应用的可聚合单体及其合成方法。含有N-乙酰
葡萄糖胺的可聚合
配体比NAG本身更强烈地结合于溶菌酶。当引入一个间隔臂,例如
6-氨基己酸(6-ACA)时,结合进一步增强。这些共轭
配体可用于预防和治疗细菌和病毒感染。此外,这些
配体可以与刺激敏感聚合物耦合,并用于恢复
生物分子。该方法可以扩展到其他
配体,例如
唾液酸,相应的聚合物可用于预防流感和轮状病毒感染。